Covaxin’s phase 1 trial result shows robust immune response mild adverse events – Hindustan Times

0
7

Hyderabad-based Bharat Biotech on Wednesday released the results of the Phase 1 trials of its coronavirus (Covid-19) vaccine ‘Covaxin’ – which produced a robust immune response against the disease an… [read more]